BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 14613932)

  • 1. Tyr-317 phosphorylation increases Shc structural rigidity and reduces coupling of domain motions remote from the phosphorylation site as revealed by molecular dynamics simulations.
    Suenaga A; Kiyatkin AB; Hatakeyama M; Futatsugi N; Okimoto N; Hirano Y; Narumi T; Kawai A; Susukita R; Koishi T; Furusawa H; Yasuoka K; Takada N; Ohno Y; Taiji M; Ebisuzaki T; Hoek JB; Konagaya A; Kholodenko BN
    J Biol Chem; 2004 Feb; 279(6):4657-62. PubMed ID: 14613932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The src homology 2 and phosphotyrosine binding domains of the ShcC adaptor protein function as inhibitors of mitogenic signaling by the epidermal growth factor receptor.
    O'Bryan JP; Lambert QT; Der CJ
    J Biol Chem; 1998 Aug; 273(32):20431-7. PubMed ID: 9685397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Shc phosphotyrosine-binding domain dominantly interacts with epidermal growth factor receptors and mediates Ras activation in intact cells.
    Sakaguchi K; Okabayashi Y; Kido Y; Kimura S; Matsumura Y; Inushima K; Kasuga M
    Mol Endocrinol; 1998 Apr; 12(4):536-43. PubMed ID: 9544989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular dynamics simulations reveal that Tyr-317 phosphorylation reduces Shc binding affinity for phosphotyrosyl residues of epidermal growth factor receptor.
    Suenaga A; Hatakeyama M; Kiyatkin AB; Radhakrishnan R; Taiji M; Kholodenko BN
    Biophys J; 2009 Mar; 96(6):2278-88. PubMed ID: 19289054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of residues that control specific binding of the Shc phosphotyrosine-binding domain to phosphotyrosine sites.
    van der Geer P; Wiley S; Gish GD; Lai VK; Stephens R; White MF; Kaplan D; Pawson T
    Proc Natl Acad Sci U S A; 1996 Feb; 93(3):963-8. PubMed ID: 8577769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A conserved amino-terminal Shc domain binds to phosphotyrosine motifs in activated receptors and phosphopeptides.
    van der Geer P; Wiley S; Lai VK; Olivier JP; Gish GD; Stephens R; Kaplan D; Shoelson S; Pawson T
    Curr Biol; 1995 Apr; 5(4):404-12. PubMed ID: 7542991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A mammalian adaptor protein with conserved Src homology 2 and phosphotyrosine-binding domains is related to Shc and is specifically expressed in the brain.
    O'Bryan JP; Songyang Z; Cantley L; Der CJ; Pawson T
    Proc Natl Acad Sci U S A; 1996 Apr; 93(7):2729-34. PubMed ID: 8610109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A phosphorylation-dependent gating mechanism controls the SH2 domain interactions of the Shc adaptor protein.
    George R; Schuller AC; Harris R; Ladbury JE
    J Mol Biol; 2008 Mar; 377(3):740-7. PubMed ID: 18279888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phosphotyrosine binding domains of Shc and insulin receptor substrate 1 recognize the NPXpY motif in a thermodynamically distinct manner.
    Farooq A; Plotnikova O; Zeng L; Zhou MM
    J Biol Chem; 1999 Mar; 274(10):6114-21. PubMed ID: 10037694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of the Src homology 2 (SH2) domain and C-terminus tyrosine phosphorylation sites of SH2-containing inositol phosphatase (SHIP) in the regulation of insulin-induced mitogenesis.
    Wada T; Sasaoka T; Ishiki M; Hori H; Haruta T; Ishihara H; Kobayashi M
    Endocrinology; 1999 Oct; 140(10):4585-94. PubMed ID: 10499514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Shc adaptor protein is highly phosphorylated at conserved, twin tyrosine residues (Y239/240) that mediate protein-protein interactions.
    van der Geer P; Wiley S; Gish GD; Pawson T
    Curr Biol; 1996 Nov; 6(11):1435-44. PubMed ID: 8939605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Binding affinities of tyrosine-phosphorylated peptides to the COOH-terminal SH2 and NH2-terminal phosphotyrosine binding domains of Shc.
    Zhou MM; Harlan JE; Wade WS; Crosby S; Ravichandran KS; Burakoff SJ; Fesik SW
    J Biol Chem; 1995 Dec; 270(52):31119-23. PubMed ID: 8537373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tyrosine phosphorylation of shc in response to B cell antigen receptor engagement depends on the SHIP inositol phosphatase.
    Ingham RJ; Okada H; Dang-Lawson M; Dinglasan J; van Der Geer P; Kurosaki T; Gold MR
    J Immunol; 1999 Dec; 163(11):5891-5. PubMed ID: 10570274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A family of Shc related proteins with conserved PTB, CH1 and SH2 regions.
    Pelicci G; Dente L; De Giuseppe A; Verducci-Galletti B; Giuli S; Mele S; Vetriani C; Giorgio M; Pandolfi PP; Cesareni G; Pelicci PG
    Oncogene; 1996 Aug; 13(3):633-41. PubMed ID: 8760305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gads is a novel SH2 and SH3 domain-containing adaptor protein that binds to tyrosine-phosphorylated Shc.
    Liu SK; McGlade CJ
    Oncogene; 1998 Dec; 17(24):3073-82. PubMed ID: 9872323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tyrosine phosphorylation of the beta 4 integrin cytoplasmic domain mediates Shc signaling to extracellular signal-regulated kinase and antagonizes formation of hemidesmosomes.
    Dans M; Gagnoux-Palacios L; Blaikie P; Klein S; Mariotti A; Giancotti FG
    J Biol Chem; 2001 Jan; 276(2):1494-502. PubMed ID: 11044453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An alternative to SH2 domains for binding tyrosine-phosphorylated proteins.
    Kavanaugh WM; Williams LT
    Science; 1994 Dec; 266(5192):1862-5. PubMed ID: 7527937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of residues within the SHC phosphotyrosine binding/phosphotyrosine interaction domain crucial for phosphopeptide interaction.
    Yajnik V; Blaikie P; Bork P; Margolis B
    J Biol Chem; 1996 Jan; 271(4):1813-6. PubMed ID: 8567619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. v-Src induces Shc binding to tyrosine 63 in the cytoplasmic domain of the LDL receptor-related protein 1.
    Barnes H; Ackermann EJ; van der Geer P
    Oncogene; 2003 Jun; 22(23):3589-97. PubMed ID: 12789267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of protein-protein interactions involved in the activation of the Shc/Grb-2 pathway by the ErbB-2 kinase.
    Ricci A; Lanfrancone L; Chiari R; Belardo G; Pertica C; Natali PG; Pelicci PG; Segatto O
    Oncogene; 1995 Oct; 11(8):1519-29. PubMed ID: 7478576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.